A Systematic Review of Patient-Reported Outcomes on the Impact of Radiation Therapy on Sexual Health in Patients With Gynecologic Cancer

26 studies, 5,646 patients: pelvic radiation reliably causes vaginal dryness, dyspareunia, and lasting sexual dysfunction — dilation helps some, not all

Journal: International Journal of Radiation Oncology, Biology, Physics | Published: 2026-02-18 | Type: Systematic Review | PMID: 41720168 Authors: Hathout L, Zhang Y, Lymberis S, Sherwani Z, Vergalasova I, Fields EC (Rutgers Cancer Institute; NYU Langone Health; Virginia Commonwealth University) Funding/COI: Not listed for either

Summary

Radiation therapy for cervical, endometrial, and vulvar cancers consistently degrades sexual function — vaginal dryness, dyspareunia, and reduced sexual satisfaction appear across studies regardless of cancer site. Sexual activity drops post-treatment, partially recovers, then plateaus. Vaginal dilation preserves length but does nothing for elasticity, and most women don't stick with it anyway.

Claims

• 26 studies met inclusion criteria from 1,402 records screened; total sample of 5,646 patients
• 25 of 26 studies were prospective in design
• 11 studies focused on cervical cancer, 7 on endometrial cancer, 8 on mixed gynecologic malignancies
• RT was "consistently associated" with vaginal dryness, dyspareunia, and diminished sexual satisfaction across study populations
• Sexual activity declined after RT, showed partial recovery over time, then stabilized — no return to baseline described
• Regular vaginal dilation was associated with maintained vaginal length and improved sexual function scores
• Vaginal dilation had no measurable effect on vaginal elasticity
• Adherence to vaginal dilation programs was characterized as low; benefits described as "modest"
• Psychological, social, and cultural factors independently shaped outcomes

Study Quality

This is a PRISMA-compliant systematic review drawing from seven databases with dual independent data extraction — a methodologically sound foundation. The 25-year search window (2000–2025) is broad enough to capture evolving RT techniques. However, this is a narrative synthesis, not a meta-analysis: no pooled effect sizes, no quantitative comparison across studies. The heterogeneity in PRO instruments used — EORTC QLQ-C30, FSFI, LENT-SOMA, SAQ among them — makes cross-study comparison difficult and is likely why the authors didn't attempt statistical pooling.

The inclusion criteria required baseline data and validated PRO instruments, which filters out the worst-quality studies. But the review excludes ovarian cancer without strong methodological justification, and funding sources for the included studies are not systematically reported, leaving conflict-of-interest exposure unclear across the evidence base.

Red Flags

• No meta-analysis: findings are directional but lack quantified effect sizes — "consistently associated" does the heavy lifting throughout
• Funding and COI not disclosed for the review itself or systematically assessed across included studies
• Heterogeneous PRO tools across 26 studies make it impossible to say how large the dysfunction burden actually is
• No breakdown by RT modality (brachytherapy vs. external beam vs. combination) in the abstract — a major omission given that technique substantially affects toxicity profile
• Dilation adherence described as "low" without reporting the actual adherence rates from included studies
• The "improvement over time then stabilization" finding is important but vague — no timeframes given for when stabilization occurs

Strengths

• Large aggregated sample (5,646 patients) across 26 prospective studies
• Rigorous search across seven databases with PRISMA methodology and dual reviewers
• Baseline data required for inclusion — eliminates retrospective recall bias from the evidence base
• Explicitly acknowledges psychosocial and cultural moderators, not just physical outcomes
• Covers three distinct gynecologic cancer sites rather than a single site

Verdict

This review confirms what clinicians already suspect — pelvic radiation damages sexual function and the damage is durable — but stops short of telling us by how much, for whom, or which RT approach is worst. The absence of a meta-analysis is the central limitation: with 26 prospective studies and 5,646 patients, a quantitative synthesis was feasible and its absence leaves the review's core message frustratingly imprecise. Worth reading for the landscape overview and the dilation finding (length yes, elasticity no), but clinicians and researchers wanting effect sizes will need to go back to the primary studies themselves.